Nestlé Earnings Call Transcripts
Fiscal Year 2026
-
Q3 organic growth reached 4%, led by volume, with improvement across regions and categories. FY 2026 guidance was maintained, while Russia deconsolidation and inflation remain key considerations.
-
Four consecutive quarters of RIG-led growth were achieved, with coffee and pet segments exceeding 2% and strong innovation in high-growth categories. North America faces challenges in frozen food and select brands, but interventions are underway. Margin recovery above 17% UTOP is expected, supported by cost savings, portfolio focus, and digital adaptation.
-
Solid H1 2026 results with 3.6% organic growth, improved profitability, and strong free cash flow. Portfolio sharpening and cost savings enabled reinvestment in growth, while guidance for 2026 was tightened to 3%-4% organic growth and higher margins.
-
The session highlighted a strategic shift to RIG-led growth, portfolio simplification, and a cultural focus on competitiveness and innovation. Coffee, petcare, and nutrition are prioritized for growth, with digital transformation and AI driving efficiency and consumer engagement.
-
Q1 2026 saw 3.5% organic sales growth, led by Coffee and emerging markets, despite headwinds from an infant formula recall and currency impacts. Guidance for 2026 is unchanged, with a focus on RIG-led growth, portfolio optimization, and resilience amid geopolitical uncertainties.
-
A new independent Chair and CEO outlined a renewed strategic focus on core businesses, efficiency, and innovation, with a proposed dividend increase and strengthened governance. The board is being refreshed, and cost savings of CHF 3 billion are targeted by 2027.
Fiscal Year 2025
-
Nespresso remains globally managed, while the company sharpens focus on four strategic pillars and sells its remaining ice cream businesses to Froneri. The infant formula recall is being managed with enhanced quality controls, and organic growth guidance is set at 3–4%.
-
Growth accelerated in 2025 with 3.5% organic growth and strong free cash flow, despite margin pressure from input costs and a significant infant formula recall. 2026 guidance targets 3–4% organic growth, margin improvement, and over CHF 9 billion free cash flow, with continued portfolio focus and efficiency gains.
-
Year-to-date organic growth accelerated to 3.3% with strong Q3 momentum, driven by investments in priority areas and improved performance in underperforming segments. Major restructuring and efficiency initiatives are underway, with a focus on RIG-led growth and a medium-term margin target above 17%.
-
A new CEO with a strong track record has been appointed following a conduct investigation, with succession planning enabling a swift transition. Operational focus is on standardized KPIs, targeted innovation, and addressing underperformers. Pet food and coffee remain growth drivers, while pricing actions and cost efficiencies support margin guidance despite external pressures.
-
Organic sales grew 2.9% in H1 2025, with U-top margin at 16.5% despite FX and input cost headwinds. Full-year guidance is maintained, but H2 margins will be lower due to rising costs and tariffs. Strategic focus includes efficiency gains, premiumization, and a shift in China to consumer demand.
-
Leadership is driving alignment and transformation by focusing on core brands, innovation, and operational efficiency. Strategic investments target high-potential categories, while productivity gains and technology adoption support sustainable growth. Consumer trends in health, wellness, and pet care remain strong.
-
Organic sales grew 2.8% in Q1 2025, driven by pricing actions in coffee and confectionery, while cost savings and increased marketing investment support future growth. Guidance for improved organic sales and a UTOP margin at or above 16% is maintained.
-
2024 was marked by global instability and inflation, impacting growth and trust. Leadership changes, a robust cost savings program, and strategic focus on core brands and innovation aim to accelerate performance. Dividend increases and board strengthening reflect confidence in future growth.
-
The event outlined a strategy focused on accelerating growth through investment, efficiency, and innovation, with a CHF 2.5 billion cost-saving program funding category expansion and digital transformation. Key growth drivers include core brand expansion, innovation big bets, and addressing underperformance, especially in the Americas, while leadership emphasized speed, focus, and sustainability.
Fiscal Year 2024
-
2024 results met or exceeded guidance, with 2.2% organic growth and strong cash flow despite FX and commodity headwinds. Strategic cost savings and organizational changes are funding growth investments, with 2025 guidance targeting improved organic sales and a UTOP margin at or above 16%.
-
2024 results met or exceeded guidance, with 2.2% organic sales growth and strong cash flow. Cost savings and organizational changes are fueling investments in growth, while 2025 guidance anticipates improved organic sales and a UTOP margin at or above 16%.
-
Revised summary: Management is driving growth through operational excellence, portfolio focus, and increased marketing, with a new innovation model. Targets are 4%+ organic growth, 17%+ margins, and CHF 2.5B in cost savings. Growth drivers include coffee, PetCare, nutrition, food, and confectionery, with digital and sustainability integrated.
-
Organic growth reached 2% for the first nine months, led by coffee, pet care, and confectionery, but softening consumer demand and inventory reductions prompted a downward revision of full-year guidance. The company is restructuring, prioritizing investment, and expects margins to be around 17% with flat EPS year-on-year.
-
Leadership transition prioritizes consumer-centric growth, with new CEO focusing on organic growth, brand investment, and organizational alignment. Despite challenging markets, guidance for over 3% organic growth holds, with margin investments funded by efficiency gains.
-
A new CEO has been appointed to drive a strategic shift toward core strengths, market share gains, and operational excellence. The focus will be on brand investment, productivity, and digital transformation, with no changes to current financial guidance.
-
Strong real internal growth and market share gains were achieved in H1 2024, with e-commerce and innovation driving performance. Gross margin improved but will face H2 pressure from rising coffee and cocoa costs, while organic growth guidance was revised to at least 3% due to increased promotional activity.
-
H1 2024 saw a return to RIG-led growth, with strong performance in coffee, pet care, and e-commerce channels. Gross profit margin and free cash flow improved, but guidance for organic sales growth was revised to at least 3% due to a tougher pricing environment.
-
Reported sales declined amid currency effects and softer demand, while margins and underlying EPS improved; the proposed dividend rose to CHF 3/share. Growth plans emphasize higher volume and mix, nutrition, operational execution and sustainability.
Fiscal Year 2023
Fiscal Year 2022
-
2021 organic sales growth reached 7.5%, with strong results in PetCare, Health Science and coffee; e-commerce reached 14.3% of sales. Emissions fell in 2021, alongside continued climate and nutrition commitments.
Fiscal Year 2021
-
FY21 organic growth reached 7.5%, led by PetCare, Health Science and coffee, while inflation compressed margins and cash flow. FY22 guidance calls for ~5% organic growth, with pricing and efficiency actions continuing amid cost pressures.
-
Input inflation is expected to rise in 2022, with pricing and revenue-management actions intended to offset pressure. Growth priorities include North American capacity, health science expansion and continued investment in plant-based products.
Fiscal Year 2020
-
2020 organic growth reached 3.6% and underlying margin improved, despite FX, divestitures and pandemic disruption. Guidance called for further growth in 2021 and sustained mid-single-digit organic growth from 2022.
-
H1 organic growth was 2.8%, with conservative FY guidance of 2%-3% amid uncertainty and a gradual out-of-home recovery. Growth priorities included U.S. portfolio renewal and e-commerce, continued cost efficiencies, selective acquisitions and sustainability investment.
-
2019 organic growth reached 3.5%, with premiumization and portfolio actions supporting results. Mid-single-digit organic growth is targeted sustainably in 2021 or possibly 2022, while 2020 M&A activity was expected to be busy.
Fiscal Year 2019
-
2019 sales reached CHF 92.6 billion, with 3.5% organic growth and a 17.6% underlying margin. Margin targets were achieved early, but 4%-6% organic growth was pushed back by about a year; China disruption and portfolio transitions clouded near-term growth.
-
H1 organic growth reached 3.6%, with FY19 margin improvement expected at least 50 bps and the 2020 margin target’s lower end expected in 2019. Zone AOA growth priorities include premiumization, digital, Starbucks launches and pet care.
-
Regional management is reducing costs while funding innovation and share gains; 60% of sales gained or maintained share, versus 40% a few years earlier. The outlook targets ~2% average organic growth under flat pricing, with continued margin improvement and growth investment.
-
2018 brought stronger growth, record cash flow and accelerating U.S. sales, supported by portfolio shifts, innovation and cost savings. Priorities included meeting 2020 growth and margin targets while investing more in U.S. growth.
Fiscal Year 2018
-
2018 sales reached CHF 91.4 billion, with organic growth improving to 3% and underlying trading operating profit margin up 50 bps. Guidance calls for further growth and margin improvement in 2019, progressing toward 2020 targets.
-
Growth plans centered on reinvesting cost efficiencies in brands, innovation and digital, with coffee and pet care as major pillars. Underlying trading operating profit improved 60 bps in 2017, with a 150–250 bps improvement target by 2020.
-
A $7.15bn perpetual global license adds Starbucks retail and food service coffee products, strengthening North American presence and creating international growth opportunities. The deal is expected to be EPS-accretive in 2019, with limited CapEx and no change to the share buyback.
-
The 2020 agenda combines portfolio upgrades, stronger innovation and cost reductions to target mid-single-digit growth and 150–250 bps of margin improvement. U.S. growth, e-commerce and high-growth channels are central priorities.
Fiscal Year 2017
-
FY17 organic growth was 2.4%, led by 1.6% RIG, while underlying margin rose 50 bps in constant currency. FY18 growth guidance was 2%-4%, with portfolio shifts, innovation and cost efficiency underpinning the reaffirmed 2020 targets.
Fiscal Year 2016
-
FY 2016 organic growth was 3.2%, with strong volume but softer-than-expected pricing; margins and cash flow improved despite higher restructuring costs. FY 2017 guidance was 2%-4% growth, with stable margin including restructuring.
-
Regional launches and digital capabilities were central growth levers, alongside China’s Yinlu turnaround and efficiency programs. Management maintained a 5%-6% growth ambition and targeted more than 200 bps of annual structural savings by 2019-2020.
-
Priorities centered on profitable growth through portfolio choices, innovation, efficiency and consumer relevance. Presentations highlighted Americas momentum, global coffee and pet-care opportunities, EMENA actions and water’s growth and sustainability agenda.
Fiscal Year 2015
Fiscal Year 2014
Fiscal Year 2013
-
Americas sales reached ~CHF 41B and grew 5.9% last year, with varied category results and growth opportunities in coffee, pet care and emerging formats. Priorities included innovation, route optimization and nutrition, sustainability and rural development initiatives.
Fiscal Year 2012
-
2012 sales grew 5.9% organically, trading margin reached 15.2%, and operating cash flow rose to CHF 15.8bn. FY 2013 guidance remained 5%-6% organic growth with improved margins and underlying EPS.